Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Jun 29, 2026
Expenses
$70,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
District of Columbia
Lobbyists on this filing
1
-
COOKAB HASHEMIPreviously held: Senior Director, Government Affairs & Reimbursement Policy
Government bodies contacted
8
Lobbying activity
6
Medicare Reimbursement and general Medicaid issues ROCR, H.R.1031 and S.2021
Radiation Oncology, Radiation Therapy, Oncology issues, ROCR Value Based Program Act of 2025, H.R. 2120/S. 1031 Cancer Care
Trade issues between the U.S. and EU, US and China and U.S. - UK USMCA
Tariffs policies between US - EU, US - UK and US - China USMCA
Nuclear Security issues, Nuclear Health issues, Cobalt 60 Gamma Knife
Labor-HHS and AG-FDA appropriations bills